IOL Chemicals and Pharmaceuticals is currently trading at Rs. 74.50, up by 2.57 points or 3.57% from its previous closing of Rs. 71.93 on the BSE.

The scrip opened at Rs. 73.85 and has touched a high and low of Rs. 75.35 and Rs. 73.28 respectively. So far 40481 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 126.60 on 19-Sep-2025 and a 52 week low of Rs. 57.51 on 07-Apr-2025.

Last one week high and low of the scrip stood at Rs. 75.88 and Rs. 71.21 respectively. The current market cap of the company is Rs. 2186.78 crore.

The promoters holding in the company stood at 52.62%, while Institutions and Non-Institutions held 2.10% and 45.28% respectively.

IOL Chemicals and Pharmaceuticals has secured Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & Health Care (EDQM) for its API product ‘CLOPIDOGREL BESILATE’ on February 23, 2026. The company has an existing valid CEP for ‘CLOPIDOGREL BISULPHATE.’ Clopidogrel is an antiplatelet medication used in the treatment and prevention of cardiovascular diseases.

IOL Chemicals and Pharmaceuticals is India's one of the leading generic pharmaceutical companies, and is significant player in the Organic chemicals space.